Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $559.07 million. The enterprise value is $320.93 million.
| Market Cap | 559.07M |
| Enterprise Value | 320.93M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MNMD has 70.50 million shares outstanding. The number of shares has increased by 25.69% in one year.
| Shares Outstanding | 70.50M |
| Shares Change (YoY) | +25.69% |
| Shares Change (QoQ) | +18.95% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 48.96% |
| Float | 58.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -287.75 |
Financial Efficiency
Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -45.28%.
| Return on Equity (ROE) | -105.30% |
| Return on Assets (ROA) | -73.30% |
| Return on Capital (ROIC) | -45.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.20M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.52% in the last 52 weeks. The beta is 2.39, so MNMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.39 |
| 52-Week Price Change | +64.52% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 54.09 |
| Average Volume (20 Days) | 1,680,674 |
Short Selling Information
The latest short interest is 7.38 million, so 10.47% of the outstanding shares have been sold short.
| Short Interest | 7.38M |
| Short Previous Month | 6.74M |
| Short % of Shares Out | 10.47% |
| Short % of Float | 12.57% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -95.21M |
| Pretax Income | -125.32M |
| Net Income | -125.32M |
| EBITDA | -122.00M |
| EBIT | -124.88M |
| Earnings Per Share (EPS) | -$2.94 |
Balance Sheet
The company has $252.33 million in cash and $14.19 million in debt, giving a net cash position of $238.14 million or $3.38 per share.
| Cash & Cash Equivalents | 252.33M |
| Total Debt | 14.19M |
| Net Cash | 238.14M |
| Net Cash Per Share | $3.38 |
| Equity (Book Value) | 196.06M |
| Book Value Per Share | 2.78 |
| Working Capital | 190.20M |
Cash Flow
| Operating Cash Flow | -67.63M |
| Capital Expenditures | n/a |
| Free Cash Flow | -67.63M |
| FCF Per Share | -$1.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.69% |
| Shareholder Yield | -25.69% |
| Earnings Yield | -22.42% |
| FCF Yield | -12.10% |
Analyst Forecast
The average price target for MNMD is $25.86, which is 226.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.86 |
| Price Target Difference | 226.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |